FDA Inspection
Amryt Pharmaceuticals, Inc.Amryt Pharmaceuticals, Inc. – FDA Inspection, Jan 23, 2020
Record Details
This FDA Inspection record concerns Amryt Pharmaceuticals, Inc., with an inspection on January 23, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Amryt Pharmaceuticals, Inc.
- Inspection Date
- January 23, 2020
- Product Type
- Drugs
View Company Profile
ID · ea72e082-e7f6-4428-b809-fae7e3ab5b9f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1122448
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Amryt Pharmaceuticals, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 14, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 16, 2015 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 27, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Amryt Pharmaceuticals, Inc.
- FDA Inspection 1180597 - 2022-09-14
- FDA Inspection 947089 - 2015-07-16
- FDA Inspection 797858 - 2012-08-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.